Xi Wu

State Key Laboratory Of Medicinal Chemical Biology, College Of Pharmacy And Key Laboratory Of Molecular Drug Research
Changhongjie, 300350, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Research trends and hotspots of electroacupuncture for depression: a bibliometric and visual analysis (2005-2025).

Research trends and hotspots of electroacupuncture for depression: a bibliometric and visual analysis (2005-2025).

Journal: Frontiers in psychiatry
Published: December 12, 2025

Corrigendum to "Fibroblast growth factor receptor inhibitors ameliorate metabolic dysfunction-associated steatohepatitis by modulating the glycine-glutathione-gut microbiota axis" [Free Rad. Biol. Med. 240 (2025) 410-425].

Corrigendum to "Fibroblast growth factor receptor inhibitors ameliorate metabolic dysfunction-associated steatohepatitis by modulating the glycine-glutathione-gut microbiota axis" [Free Rad. Biol. Med. 240 (2025) 410-425].

Journal: Free radical biology & medicine
Published: November 16, 2025

Remdesivir alleviates inflammation and tissue damage in experimental colitis via AnxA5 Signaling.

Remdesivir alleviates inflammation and tissue damage in experimental colitis via AnxA5 Signaling.

Journal: International immunopharmacology
Published: September 09, 2025

Atorvastatin alleviates the progression of fibrosis in experimental systemic sclerosis: Binding to macrophage CD14 to regulate TLR4/p65 or directly modulating fibroblast Smad3 signaling.

Atorvastatin alleviates the progression of fibrosis in experimental systemic sclerosis: Binding to macrophage CD14 to regulate TLR4/p65 or directly modulating fibroblast Smad3 signaling.

Journal: Free radical biology & medicine
Published: September 08, 2025

Fibroblast growth factor receptor inhibitors ameliorate metabolic dysfunction-associated steatohepatitis by modulating the glycine-glutathione-gut microbiota axis.

Fibroblast growth factor receptor inhibitors ameliorate metabolic dysfunction-associated steatohepatitis by modulating the glycine-glutathione-gut microbiota axis.

Journal: Free radical biology & medicine
Published: June 30, 2025

Freezing shock monocytes deliver antisense oligonucleotides via liposomes for the treatment of idiopathic pulmonary fibrosis.

Freezing shock monocytes deliver antisense oligonucleotides via liposomes for the treatment of idiopathic pulmonary fibrosis.

Journal: Asian journal of pharmaceutical sciences
Published: June 03, 2025

Locked nucleic acid-modified antisense oligonucleotides attenuate scar hyperplasia through targeted inhibition of CTGF.

Locked nucleic acid-modified antisense oligonucleotides attenuate scar hyperplasia through targeted inhibition of CTGF.

Journal: Frontiers in pharmacology
Published: May 06, 2025

Active Targets and Potential Mechanisms of Erhuang Quzhi Formula in Treating NAFLD: Network Analysis and Experimental Assessment.

Active Targets and Potential Mechanisms of Erhuang Quzhi Formula in Treating NAFLD: Network Analysis and Experimental Assessment.

Journal: Cell biochemistry and biophysics
Published: July 04, 2024

Echinocystic acid inhibits sepsis-associated renal inflammation and apoptosis by targeting protein tyrosine phosphatase 1B.

Echinocystic acid inhibits sepsis-associated renal inflammation and apoptosis by targeting protein tyrosine phosphatase 1B.

Journal: International immunopharmacology
Published: May 14, 2024

Evaluation of nintedanib efficacy: Attenuating the lens fibrosis in vitro and vivo.

Evaluation of nintedanib efficacy: Attenuating the lens fibrosis in vitro and vivo.

Journal: International immunopharmacology
Published: April 08, 2024

Electroacupuncture treatment ameliorates metabolic disorders in obese ZDF rats by regulating liver energy metabolism and gut microbiota.

Electroacupuncture treatment ameliorates metabolic disorders in obese ZDF rats by regulating liver energy metabolism and gut microbiota.

Journal: Frontiers in endocrinology
Published: April 17, 2023

Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.

Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.

Journal: Journal of ethnopharmacology
Published: January 19, 2023
Showing 1-12 of 16

Last Updated: 09/26/2026